Lurker Nancy

Lurker Nancy is listed in filings as Director at Alkermes plc. This profile follows SEC Form 4 activity through May 22, 2026, including sale activity and purchase activity. Recent filings connect the profile to Alkermes plc (ALKS), Collegium Pharmaceutical, Inc. (COLL), and EyePoint Pharmaceuticals, Inc. (EYPT). The current snapshot covers public activity from Jul 12, 2024 to May 22, 2026. Reported amounts are shown as $54.5K to $161.9K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.